{"disease":{"id":"nomid","name":"nomid"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02974595","title":"Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases (NOMID/CAPS, DIRA, CANDLE, SAVI, NLRC4-MAS, Still'S-like Diseases, and Other Undifferentiated Autoinflammatory Diseases)","phase":"","overall_status":"RECRUITING","enrollment_count":3200,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT03526224","title":"Teriflunomide Tecfidera LMCE","phase":"","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"University at Buffalo","has_results":false},{"nct_id":"NCT05937191","title":"Leflunomide for Idiopathic Pulmonary Hemosiderosis in Children","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":34,"lead_sponsor_name":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","has_results":false},{"nct_id":"NCT00770601","title":"Canakinumab to Treat Neonatal-Onset Multisystem Inflammatory Disease","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":7,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}